Pannex Therapeutics
Developing anti-addictive painkillers to save lives
Based based in New York, New York, US, Pannex Therapeutics works in biopharma, founded in 2020.
Profile
Pannex Therapeutics is a pioneer biopharmaceutical company totally focused on the development of a novel therapeutic class of Pannexin 1 channel (Panx1) blockers. Pannex is developing a platform of small molecules that blocks this exciting new pharmacological target, Panx1 channels. With potential applications in many therapeutic areas, the initial focus is on chronic pain treatment and the prevention of opioid addiction.
As a business in biopharma, Pannex Therapeutics is listed here with the public details available about it.
New York, New York, US is where the company is located.
The company is listed at the SOSV portfolio company stage of development.
Recorded headcount: 2-10 employees.
Public records show total funding of about $2.5M.
| Sector | Biopharma |
|---|---|
| Headquarters | New York, New York, US |
| Country | Chile |
| Founded | 2020 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $2,500,000 |
Website: pannextherapeutics.com
Browse related
Create a free account